Skip to main content
. 2013 Apr 4;98(6):2422–2429. doi: 10.1210/jc.2013-1157

Table 1.

Demographics and Baseline Characteristics (All Enrolled Subjects)

AGHD Patients (n = 53) Matched Controls (n = 48)
Sex, n, %
    Male 31 (58.5) 30 (62.5)
    Female 22 (41.5) 18 (37.5)
Race, n, %a
    White 49 (92.5) 29 (60.4)
    Black or African American 2 (3.8) 18 (37.5)
    Asian 2 (3.8) 0 (0.0)
    Other 0 (0.0) 1 (2.1)
Ethnicity, n, %
    Hispanic or Latino 11 (20.8) 9 (18.8)
    Not Hispanic or Latino 42 (79.2) 39 (81.3)
Age, y, n, %
    Mean (SD) 52 (13.4) 53 (12.9)
Estrogen status, n, %
    None 12 (22.6) 12 (25.0)
    Oral 9 (17.0) 6 (12.5)
    Patch 1 (1.9) 0 (0.0)
BMI, kg/m2, n, %
    Lean (<25) 7 (13.2) 7 (14.6)
    Overweight (≥25 and < 30) 15 (28.3) 13 (27.1)
    Obese (≥30) 31 (58.5) 28 (58.3)
    Mean 32.1 (7.4) 31.8 (7.1)
Etiology, n, %b NA
Pituitary adenoma 34 (64.2)
CNS tumors 8 (15.1)
Othersc 18 (34.0)

Abbreviation: CNS, central nervous system.

a

P < .05 between groups.

b

More than 1 cause may be applicable per patient.

c

Includes 11% head trauma, 4% empty sella, 6% childhood-onset GHD.